Skip to main content
Log in

The Importance of Skin Disease as Assessed by “Willingness-To-Pay”

  • Published:
Journal of Cutaneous Medicine and Surgery: Incorporating Medical and Surgical Dermatology

Abstract

Background: To achieve optimal resource allocation in health care, it is necessary to value competing resource uses according to the benefit derived from those uses. Skin disease makes as great an impact as other serious medical conditions when assessed by effects on health-related quality of life. Objective: To confirm the high impact of skin disease by comparing patients’ willingness to pay (WTP) to be cured or relieved from symptoms of skin and nonskin conditions. Methods: We searched the published literature on WTP to compare the impact of dermatologic conditions with the impact of other medical conditions. A total of 46 articles were identified of which 10 included information on willingness to pay for cure reported on a monthly basis. Results: WTP for skin diseases fell in the range of $125–260/month and was comparable or higher than all but one of the other identified conditions. Conclusion: Willingness to pay for relief from skin diseases is comparable to that for relief of other serious medical conditions. Skin diseases are associated with a significant adverse impact on patients’ lives.

Antécédents

En vue de parvenir à une allocation optimale des ressources médicales, il est nécessaire d’en évaluer les différents usages selon les avantages de chacun. La maladie de la peau a le même effet sur la qualité de vie que toute autre maladie grave. Objectif: Confirmer 1’impact important de la maladie de la peau en comparant la volonté de payer (VDP) des patients afin de soulager les symptômes associés aux maladies de la peau et ceux associés à d’autres maladies. Méthodes: Nous avons effectué des recherches sur les publications traitant de la VDP en vue de comparer l’impact des troubles dermatologiques avec l’impact d’autres sortes d’états pathologiques. En total, 46 articles ont été identifiés, dont 10 contiennent des données sur la volonté de payer pour une guérison sur une base mensuelle. Résultats: La VDP pour un trouble dermatologique varie entre 125 $ et 260 $ par mois, ce qui est comparable ou supérieur à toutes les autres pathologies, sauf une. Conclusion: La volonté de payer afin de soulager les conditions dermatologiques est comparable à celle la VDP pour soulager d’autres maladies graves. Les troubles de la peau peuvent avoir d’importants effets nuisibles sur la vie des patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • SR Rapp SR Feldman ML Exum et al. (1999) ArticleTitlePsoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 41 401–407 Occurrence Handle1:STN:280:DyaK1MzovFOmuw%3D%3D Occurrence Handle10459113

    CAS  PubMed  Google Scholar 

  • G Krueger J Koo M Lebwohl et al. (2001) ArticleTitleThe impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol 137 280–284 Occurrence Handle1:STN:280:DC%2BD3M7pvV2jsw%3D%3D Occurrence Handle11255325

    CAS  PubMed  Google Scholar 

  • A Wahl JH Loge I Wiklund et al. (2000) ArticleTitleThe burden of psoriasis: A study concerning health-related quality of life among Norwegian adult patients with psoriasis compared with general population norms. J Am Acad Dermatol 43 803–808 Occurrence Handle10.1067/mjd.2000.107501 Occurrence Handle1:STN:280:DC%2BD3M7pt1agsw%3D%3D Occurrence Handle11050584

    Article  CAS  PubMed  Google Scholar 

  • P O’Neill P Kelly (1996) ArticleTitlePostal questionnaire study of disability in the community associated with psoriasis. BMJ 313 IssueID7062 919–921 Occurrence Handle1:STN:280:ByiD3s%2FhsFI%3D Occurrence Handle8876097

    CAS  PubMed  Google Scholar 

  • M Ryan DA Scott C Reeves et al. (2001) ArticleTitleEliciting public preferences for healthcare: a systematic review of techniques. Health Technol Assess 5 1–186 Occurrence Handle1:STN:280:DC%2BD3M7msVWrtA%3D%3D

    CAS  Google Scholar 

  • JA Olsen RD Smith (2001) ArticleTitleTheory versus practice: a review of ‘willingness-to-pay’ in health and health care. Health Econ 10 39–52 Occurrence Handle10.1002/1099-1050(200101)10:1<39::AID-HEC563>3.0.CO;2-E Occurrence Handle1:STN:280:DC%2BD3M3ht1Omtg%3D%3D Occurrence Handle11180568

    Article  CAS  PubMed  Google Scholar 

  • S Birch A Gafni B O’Brien (1999) ArticleTitleWillingness to pay and the valuation of programmes for the prevention and control of influenza. Pharmacoeconomics 16 IssueIDSuppl 1 55–61 Occurrence Handle10623377

    PubMed  Google Scholar 

  • M Johannesson (1992) ArticleTitleEconomic evaluation of lipid lowering—a feasibility test of the contingent valuation approach. Health Policy 20 309–320 Occurrence Handle1:STN:280:By2B28jpsVU%3D Occurrence Handle10118015

    CAS  PubMed  Google Scholar 

  • SD Ramsey SD Sullivan BM Psaty et al. (1997) ArticleTitleWillingness to pay for antihypertensive care: evidence from a staff-model HMO. Soc Sci Med 44 1911–1917 Occurrence Handle10.1016/S0277-9536(96)00300-0 Occurrence Handle1:STN:280:ByiA3sjltFY%3D Occurrence Handle9194252

    Article  CAS  PubMed  Google Scholar 

  • M Johannesson PO Johansson B Kristrom et al. (1993) ArticleTitleWillingness to pay for antihypertensive therapy—further results. J Health Econ 12 95–108 Occurrence Handle10.1016/0167-6296(93)90042-D Occurrence Handle1:STN:280:ByyB1cnnvFY%3D Occurrence Handle10126492

    Article  CAS  PubMed  Google Scholar 

  • B Kartman F Andersson M Johannesson (1996) ArticleTitleWillingness to pay for reductions in angina pectoris attacks. Med Decis Making 16 248–253 Occurrence Handle1:STN:280:BymH3MrhsFI%3D Occurrence Handle8818123

    CAS  PubMed  Google Scholar 

  • K Blumenschein M Johannesson (1998) ArticleTitleRelationship between quality of life instruments, health state utilities, and willingness to pay in patients with asthma. Ann Allergy Asthma Immunol 80 189–194 Occurrence Handle1:STN:280:DyaK1c7lsFGmtQ%3D%3D Occurrence Handle9494453

    CAS  PubMed  Google Scholar 

  • L Lundberg M Johannesson M Silverdahl et al. (1999) ArticleTitleQuality of life, health-state utilities and willingness to pay in patients with psoriasis and atopic eczema. Br J Dermatol 141 1067–1075 Occurrence Handle10.1046/j.1365-2133.1999.03207.x Occurrence Handle1:STN:280:DC%2BD3c%2FnsVGquw%3D%3D Occurrence Handle10606854

    Article  CAS  PubMed  Google Scholar 

  • RJ Motley AY Finlay (1989) ArticleTitleHow much disability is caused by acne? Clin Exp Dermatol 14 194–198 Occurrence Handle1:STN:280:By%2BD2srks1A%3D Occurrence Handle2531637

    CAS  PubMed  Google Scholar 

  • SR Eastaugh (2000) ArticleTitleWillingness to pay in treatment of bleeding disorders. Int J Technol Assess Health Care 16 706–710 Occurrence Handle10.1017/S0266462300101266 Occurrence Handle1:STN:280:DC%2BD3cvitVKqtg%3D%3D Occurrence Handle10932435

    Article  CAS  PubMed  Google Scholar 

  • MS Thompson JL Read M Liang (1984) ArticleTitleFeasibility of willingness-to-pay measurement in chronic arthritis. Med Decis Making 4 195–215 Occurrence Handle1:STN:280:BiuB1Mvmsl0%3D Occurrence Handle6433140

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Steven R. Feldman.

About this article

Cite this article

Parks, L., Balkrishnan, R., Hamel–Gariépy, L. et al. The Importance of Skin Disease as Assessed by “Willingness-To-Pay”. JCMS 7, 369–371 (2003). https://doi.org/10.1007/s10227-002-0145-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10227-002-0145-y

Navigation